Androgenetic Alopecia: An Update of Treatment Options

被引：165

作者：

Kelly, Yanna ^{[1
,2
,5
]}

Blanco, Aline ^{[3
]}

Tosti, Antonella ^{[4
]}

机构：

[1] Univ Sao Paulo, Dept Dermatol, Sao Paulo, SP, Brazil

[2] Hosp Servidor Publ Municipal Sao Paulo, Dept Dermatol, Sao Paulo, SP, Brazil

[3] Univ Fed Mato Grosso do Sul, Dept Dermatol, Campo Grande, MS, Brazil

[4] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA

[5] 1364 Oscar Freire St, BR-05409010 Sao Paulo, SP, Brazil

来源：

DRUGS | 2016年 / 76卷 / 14期

关键词：

PATTERN HAIR LOSS; PLATELET-RICH PLASMA; FINASTERIDE; MG; 0.25-PERCENT TOPICAL SOLUTION; PROSTATE-SPECIFIC ANTIGEN; DOUBLE-BLIND; STEM-CELLS; 5-ALPHA-REDUCTASE INHIBITORS; AFFECT SPERMATOGENESIS; FOLLICLE REGENERATION;

D O I：

10.1007/s40265-016-0629-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Androgenetic alopecia (AGA) is characterized by a non-scarring progressive miniaturization of the hair follicle in predisposed men and women with a pattern distribution. Although AGA is a very prevalent condition, approved therapeutic options are limited. This article discusses the current treatment alternatives including their efficacy, safety profile, and quality of evidence. Finasteride and minoxidil for male androgenetic alopecia and minoxidil for female androgenetic alopecia still are the therapeutic options with the highest level evidence. The role of antiandrogens for female patients, the importance of adjuvant therapies, as well as new drugs and procedures are also addressed.

引用

页码：1349 / 1364

页数：16

共 167 条

[1] Raising hairs [J].

Adams, Jill U. .

NATURE BIOTECHNOLOGY, 2011, 29 (06) :474-476

[2] Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study [J].

Ali, Ayad K. ;

Heran, Balraj S. ;

Etminan, Mahyar .

PHARMACOTHERAPY, 2015, 35 (07) :687-695

[3]

American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776

[4] The effect of 5α reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men [J].

Amory, John K. ;

Wang, Christina ;

Swerdloff, Ronald S. ;

Anawalt, Bradley D. ;

Matsumoto, Alvin M. ;

Bremner, William J. ;

Walker, Susan E. ;

Haberer, Lynda J. ;

Clark, Richard V. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (05) :1659-1665

[5]

Andrasfay A, PHASE 2 STUDY EVALUA

[6] Effect of Dutasteride on the Risk of Prostate Cancer. [J].

Andriole, Gerald L. ;

Bostwick, David G. ;

Brawley, Otis W. ;

Gomella, Leonard G. ;

Marberger, Michael ;

Montorsi, Francesco ;

Pettaway, Curtis A. ;

Tammela, Teuvo L. ;

Teloken, Claudio ;

Tindall, Donald J. ;

Somerville, Matthew C. ;

Wilson, Timothy H. ;

Fowler, Ivy L. ;

Rittmaster, Roger S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (13) :1192-1202

[7] Safety and tolerability of the dual 5α-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia [J].

Andriole, GL ;

Kirby, R .

EUROPEAN UROLOGY, 2003, 44 (01) :82-88

[8]

[Anonymous], J UROL

[9]

[Anonymous], 2004, PROP

[10] The potential role of minoxidil in the hair transplantation setting [J].

Avram, MR ;

Cole, JP ;

Gandelman, M ;

Haber, R ;

Knudsen, R ;

Leavitt, ML ;

Leonard, RT ;

Puig, CJ ;

Rose, PT ;

Vogel, JE ;

Ziering, CL .

DERMATOLOGIC SURGERY, 2002, 28 (10) :894-900

← 1 2 3 4 5 6 7 8 9 10 →